Immucell Corp Stock
Your prediction
Immucell Corp Stock
Immucell Corp shows a slight decrease today, losing -€0.050 (-0.880%) compared to yesterday.
Pros and Cons of Immucell Corp in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | -0.880% | 0.893% | 10.784% | 10.784% | 10.784% | -16.912% | 10.784% |
| Vaxart Inc. | -10.000% | -25.000% | 60.142% | -36.441% | 60.714% | -57.841% | -92.308% |
| Larimar Therapeutics Inc. | -0.720% | -2.817% | -14.815% | -10.968% | -16.867% | -33.971% | -82.793% |
| aTyr Pharma Inc | - | 11.538% | 11.538% | -83.616% | -3.333% | -72.420% | -82.530% |
News
ImmuCell Q2 Profit Jumps as Margins Rise
ImmuCell(NASDAQ:ICCC) reported results for the three-month period ended June 30, 2025, on August 14, 2025, highlighting a sharp rebound in profitability with adjusted EBITDA of $1.43 million
ImmuCell Posts 18% Gain in Q2
ImmuCell (NASDAQ:ICCC), a specialist in animal health products for the dairy and beef industries, issued its earnings results for the second quarter of fiscal 2025 on August 14, 2025. The company